Per Johansson
1 – 10 of 47
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Sex steroid levels in corresponding cerebrospinal fluid and serum samples quantified by mass spectrometry in men
(
- Contribution to journal › Article
-
Mark
Development of the Swedish anticholinergic burden scale (Swe-ABS)
(
- Contribution to journal › Article
- 2022
-
Mark
Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults : Effects of Alzheimer's Disease Pathology and Cognitive Decline
(
- Contribution to journal › Article
-
Mark
Testosterone associates differently with body mass index and age in serum and cerebrospinal fluid in men
(
- Contribution to journal › Letter
-
Mark
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
(
- Contribution to journal › Article
- 2021
-
Mark
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
(
- Contribution to journal › Article
- 2020
-
Mark
Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism – A pilot study : CSF/s-T4 associated with QoL in hypothyroidism
(
- Contribution to journal › Article
-
Mark
Apathy and anxiety are early markers of Alzheimer's disease
(
- Contribution to journal › Article